Brenner B M, Milford E L
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
Am J Kidney Dis. 1993 May;21(5 Suppl 2):66-72. doi: 10.1016/0272-6386(93)70097-i.
The findings cited in this report suggest that renal allograft survival might be improved by matching nephron supply to recipient needs (analogous to prescription dialysis based on Kt/V). Methods for assessing functional graft capacity (ie, nephron number, filtration, or total microvascular surface area) are needed. Graft weights might serve as a useful alternative until better indices are devised. Measures for defining and possibly reducing recipient demands are also needed to preserve graft performance. Where gross imbalances between nephron supply and recipient demand are not likely to be corrected over the long term by engraftment of a single kidney, consideration should be given to dual kidney transplantation, currently feasible only from cadaveric, but eventually from xenogeneic sources as well. The predicted longer survival and avoidance of premature return to end-stage renal disease with the transplantation of two kidneys in certain conditions could render this approach more rational, both in clinical and economic terms, than single kidney engraftment for those at greatest risk for shortened graft survival. The dosing of larger numbers of nephrons might also lessen the risk of coexistent hypertension and thereby reduce the magnitude and tempo of immune injury to the graft.
本报告引用的研究结果表明,使肾单位供应与受者需求相匹配(类似于基于Kt/V进行的处方透析)可能会提高同种异体肾移植的存活率。需要评估移植肾功能容量的方法(即肾单位数量、滤过率或微血管总面积)。在设计出更好的指标之前,移植肾重量可能是一种有用的替代指标。还需要采取措施来确定并可能降低受者需求,以维持移植肾的功能。如果肾单位供应与受者需求之间的严重失衡不太可能通过植入单个肾脏在长期内得到纠正,那么应考虑进行双肾移植,目前双肾移植仅可采用尸体供肾,但最终也可采用异种供肾。在某些情况下,双肾移植预计具有更长的生存期,且可避免过早回到终末期肾病,这可能使这种方法在临床和经济方面比单肾移植更合理,因为对于那些移植肾存活期缩短风险最大的患者而言,单肾移植的存活期较短。移植更多数量的肾单位还可能降低并存高血压的风险,从而减轻对移植肾免疫损伤的程度和速度。